© 2005 The European Society of Cardiology. Published by Elsevier Ltd. All rights reserved.
Modelling of short QT syndrome in a heterogeneous model of the human ventricular wall
Institute of Biomedical Engineering, Universität Karlsruhe (TH) Kaiserstr. 12, 76131 Karlsruhe, Germany
Manuscript submitted 15 January 2005. Revision received 28 July 2005. Accepted after revision 3 May 2005.
*Corresponding author. Tel.: +49 721 608 27 90; fax: +49 721 608 27 89. E-mail address: daniel.weiss{at}ibt.uni-karlsruhe.de (D.L. Weiss).
| Abstract |
|---|
|
|
|---|
AIMS: A percentage of sudden cardiac death events occur in individuals with structurally normal hearts due to an abnormality in the ion channel activity. While the majority of these hereditary syndromes are well-established, little is known about the significance of the short QT syndrome.
METHODS: This study is based on discovered insights into the molecular basis of the originally described form of this disease. A biophysically detailed model of cellular electrophysiology was adapted to emulate the behaviour of cells affected by the short QT syndrome. Simulations were performed in single cell and homogeneous as well as heterogeneous anisotropic multi-cellular environment describing the human left ventricle.
RESULTS: The short QT mutation increased the activity of the repolarizing outward potassium current IKr. The heterogeneous abbreviation of the action potential duration decreased the dispersion of repolarization in heterogeneous tissue. Repolarization was homogenized and the final repolarization was shifted to epicardial sites. The transmural ECG showed a shortened QT interval and a T wave with reduced amplitude.
CONCLUSION: The altered characteristics of the mutant IKr current were consistent with experimental findings. The heterogeneous reduction of the action potential duration and the reduced T wave amplitude need to be verified by measurements.
Key Words: cellular electrophysiology, ion channels, genetics, short QT syndrome, computational model
| Introduction |
|---|
|
|
|---|
The majority of sudden cardiac death (SCD) incidence relates to structural heart disease. However, approximately 20% of the incidence occurs in individuals with structurally normal hearts [1]
A correlation between an inherited ion channelopathy and an increased risk of life threatening arrhythmic events was first reported by Keating et al.[20,
21]
. They discovered a form of the long QT (LQT) syndrome which is caused by a loss of function in KCNQ1 gene forming the KvLQT1 protein of the slow delayed rectifier potassium ion channel. This syndrome was named LQT1. In the following years, several mutations manifest by an abnormality in the electrocardiogram (ECG) and an increased risk of SCD in the absence of structural heart disease have been described (Table 1). In all cases, an abnormality in ion channel activity can lead to the development of an arrhythmogenic substrate. While most of the LQT syndromes are well-studied, little is known about the clinical implications and electrophysiological consequences of the short QT syndrome. Algra et al. [22]
analyzed 6693 consecutive patients, who underwent 24 h electrocardiography, and concluded that patients with a short QT interval exhibit an increased risk of sudden cardiac death. The retrospective character of this analysis obviated further evaluation of the data.
|
The first report of the short QT syndrome as a hereditary, clinically relevant entity was provided by Gussak et al.[23]
Gaita et al.[24]
supposed that either a factor reducing sodium or calcium inward currents or a factor increasing the potassium outward currents is responsible for short QT intervals. Furthermore, they postulated that the molecular substrate producing the shortened action potential durations (APD) and, therefore, the shortened QT interval in ECG are expressed in atrial as well as in ventricular cardiomyocytes.
Recently, Brugada and colleagues [12]
presented a study on the genetic and biophysical basis of the short QT syndrome. They identified a mutation in the rapidly activating delayed rectifier cardiac potassium channel promoting the IKr current. In human cardiomyocytes, the human ether-a-go-go-related gene (HERG) forms the
-subunit of the IKr channel; the regulatory ß-subunit is the MinK-related peptide 1 (MiRP1). MiRP1 ensures the following effects on the HERG channel: increased sensitivity of the channel to IKr blockers (E-4031 and clarithromycin), decreased sensitivity to elevation of the extracellular potassium concentration [K+]o, positive shift of the voltage-dependence of activation, and accelerated deactivation [11]
. The topology of the HERG channel is similar to other voltage-gated ion channels [25
27]
. Each HERG subunit consists of six transmembrane
-helices, with the fourth carrying seven positive charges, and a pore-loop region between the fifth and sixth transmembrane helices (S5-P loop region) that acts as the selective K+ filter [28,
29]
. Coassembly of HERG encoded by KCNH2 with MiRP1 encoded by KCNE2 reproduced the biophysical and pharmacological properties of the IKr channel [11,
30,
31]
.
In this work, a computer model of human cardiomyocytes is presented that incorporates the modifications in the rapidly activating delayed rectifier potassium current IKr due to the short QT mutation reported by Brugada et al.[12]
. This modification was obtained by curve fitting the results of computational simulations with measurement data by means of numerical optimization methods [32]
. The new model, based on the PriebeBeuckelmann description of a human ventricular myocyte, was used to reproduce the activation and repolarization in a heterogeneous and anisotropic representation of a human left ventricle. The modified characteristic of the IKr channel led to a heterogeneous abbreviation of the APD in the distinctive cardiac cells within the ventricular wall. The consequence of this homogenized repolarization was visible in the transmural ECG: the T wave showed a reduced amplitude compared with the normal physiological case.
| Materials and methods |
|---|
|
|
|---|
The simulation environment consisted of three components: cellular electrophysiology, excitation propagation and anatomical structure. A detailed biophysical model of the cellular electrophysiology described the behaviour of a single cardiomyocyte with a set of nonlinear-coupled partial differential equations. Modelling of a multi-cellular environment required an anatomical representation of the considered tissue and a method defining the electrical coupling of excitable cells. Both a thin, three-dimensional parallelepiped bidomain model and a three-dimensional whole heart monodomain model were used to study propagation.
| Measurement data |
|---|
|
|
|---|
Brugada et al. identified and genetically screened three unrelated families with short QT associations [12]
| Modelling cellular electrophysiology |
|---|
|
|
|---|
A modified PriebeBeuckelmann (PB) model [33]
![]() |
Special focus was given on the rapidly activating delayed rectifier potassium current IKr, since it is the parameter to be modified for reconstructing short QT syndrome in human ventricular myocytes. The definition of IKr is given by
![]() |
![]() |
and the time constant
Xr are described by the voltage-dependent rate constants
Xr and ßXr
![]() |
![]() |
|
| Model adaptation |
|---|
|
|
|---|
To adapt the behaviour of the modelled cardiomyocytes to the measured mutant cells, the single mathematical model of a human cardiac M cell was stimulated. The same environmental conditions as in the patch clamp measurement [12]
For the subsequent simulations the temperature was raised to 310.15 K to perform simulations at body temperature. A Q10 of three for the kinetics of the channel was assumed [37]
. The 14 K increase resulted in an approximately five times reduced time constant
Xr. The acceleration of the opening of the activation gate Xr led to an increased repolarizing current IKr. To consider a heterozygous expression, the mutant IKr channel formulation was combined with the wild-type representation [34]
. In this configuration representing the short QT mutation both the N588K/KCNE2 and the wild-type HERG/KCNE2 channel reproduced 50% of the resulting IKr current.
| Heterogeneity |
|---|
|
|
|---|
Cells isolated from different regions within the ventricular wall display a different characteristic response to pharmacological agents, expression of pathology, and their electrophysiological properties [38]
Formalisms were integrated in the model to represent this transmural electrophysiological heterogeneity within the ventricle in a preliminary study [34]
. Smooth gradients of maximum ion channel conductivity and, therefore, gradients in current densities across the virtual wall affect the distinctive behaviour of the transmurally varying cell types. Changes in four different ionic currents were considered. The involved potassium currents were the transient outward current Ito, the slow delayed rectifier current IKs, and the inward rectifier current IK1 [39,
40]
. Also, the findings of a study [41]
reporting transmural changes of the Na+/Ca2+ exchange current in canine myocytes with a reduced current density in endocardial cells were included in the cellular model.
In the model of the left ventricular wall the M cells were located relatively near to the endocardium. A realistic upright positive T wave in transmurally computed ECG was obtained with this configuration and the heterogeneous distribution as well as the smooth transition of ion channel density across the ventricular wall [42]
.
| Excitation propagation |
|---|
|
|
|---|
A bidomain diffusion model depicting current flow through gap junctions and intracellular as well as extracellular space ensured anisotropic electrical coupling of the cells [43,
| Anatomical model |
|---|
|
|
|---|
A detailed three-dimensional anatomical data set of a female left ventricle applying data from the Visible Human Project was created [45]
|
A long and thin three-dimensional parallelepiped domain was used to calculate extracellular potentials in the tissue and the surrounding bath medium. It describes an approximately one-dimensional line from endocardium to epicardium through the ventricular wall and considers transmural heterogeneity of the electrophysiological properties within the tissue in the absence of electrical anisotropy. This thin representation to simulate excitation conduction across the heart wall consists of 96 × 9 × 9 cubic voxels with an edge length of 0.2 mm and is surrounded by a bath with a thickness of 5 voxels in each direction.
| Computational environment |
|---|
|
|
|---|
The three-dimensional ventricular simulation was performed on 10 Apple XServe G5 dual 2 GHz processor cluster nodes using multiprocessing techniques [48]
| Results |
|---|
|
|
|---|
A new description for the rapidly activating delayed rectifier potassium current IKr was developed to model the behaviour of a cardiomyocyte affected by the short QT mutation. Because of the homogeneous distribution of the IKr current in the ventricular wall [40]
![]() |
![]() |
![]() |
![]() |
![]() |
Xr and ßXr of the activation gate Xr for the IKr current were modulated. The half-activation voltage aXr,V0.5 was shifted to negative values and the amplifying factor aXr,1 was increased to realize a faster activation and consequently an increased activity of IKr. The abolished rectification and accelerated tail current decay were obtained by shifting the half-activation voltage bXr,V0.5 to a more positive value and an elevated intensifying factor bXr,1.
The measurement of the IKr current performed by Brugada et al. was reproduced (Fig. 3 in Ref. [12]
). Simulation with our M cell representation of the wild-type modification of the PriebeBeuckelmann cellular model [34]
displayed the behaviour of a healthy cardiomyocyte. The inward rectification factor rik of IKr led to a reduction of this ionic current activity within the whole physiological range of potentials. This effect was augmented at voltages above rikV0.5. A slowly deactivating inward tail current caused by the repolarizing step was generated. The steady-state IKr current reached its maximum at nearly 0 mV and decreased at more positive potentials. The mutant definition of IKr describing the N588K/KCNE2 channel was integrated in the wild-type M cell model. As in the measurement, the virtual mutation abolished the rectification of the IKr channel due to the amplifying background substitution component bs. The current density during depolarization was increased and the tail current elicited by the repolarizing pulse displays accelerated kinetics. The smallest root-mean-square error under environmental conditions corresponding to the measurement and thus the best match between the N588K/KCNE2 emulating mathematical model and the measured N588K/KCNE2 mutant IKr channel [12]
was found for the parameters of the IKr definition shown in the right column of Table 2. Fig. 2 compares the voltage-dependent course of rik for the wild-type and bs for the mutant modelling (left). The influence of the voltage-shifting in the mutant case on the gating-like components of the activation gate Xr is also shown (right). Fig. 3 demonstrates the course of the IKr current (top) and the normalized steady-state currents (bottom) for the wild-type (left) and the mutant (right) modelling during penetration with the stimulation protocol described by Brugada et al.[12]
.
|
|
The action potentials at body temperature in consideration of coexpressed wild-type and mutant channels to mimic heterozygous conditions were markedly abbreviated under the influence of the short QT mutation. The differences in APD between the distinctive cardiac cell types were decreased. In wild-type the maximum difference of the APD90 in a homogeneous tissue is 72 ms between epicardium and M cells whereas in the mutant modelling it is reduced to 29 ms. Fig. 4 displays on the top the 30th elicited action potential at a stimulus frequency of 1 Hz for the wild-type (left) and the short QT mutant modelling (right). The altered kinetics of the mutant IKr current during an action potential was determined as in the experiment by Brugada et al. (Fig. 3G in Ref. [12]
The electrophysiological heterogeneity was introduced into a parallelepiped domain, replicating a line through the left ventricle from endocardium to epicardium. The two bottom panels in Fig. 4 illustrate the effect of the heterogeneous expression of the ion channels on the electrical activity of the distinctive cell types within the virtual wall. The differences of the action potential shapes and durations are reduced for both the wild-type and mutant case. The short QT mutation barely influenced the activation but resulted in a marked abbreviation of the repolarization time and decreased dispersion of repolarization. The maximum difference of the APD90 decreases from 43 ms in the wild-type to 27 ms in the mutant case, see Fig. 6.
|
|
|
To determine the consequences of the short QT mutation in a complex three-dimensional model the transmurally heterogeneous configuration was included in an anisotropic model of the human left ventricle. The colour-coded transmembrane voltages during depolarization, plateau phase and repolarization for the wild-type as well as the mutant case are shown in Figs. 7 and 8, respectively. In both cases, the depolarization started at the apical endocardial site and wandered in a basal epicardial direction. During the plateau phase no significant transmural gradient of Vm was present. In wild-type the final repolarization was located in midmyocardial areas near the M cells. In short QT mutant case the time to repolarization was markedly reduced and homogenized for the distinctive cell types within the ventricular wall. The final repolarization was shifted to the epicardial region.
|
|
An approximate transmural ECG was computed in the parallelepiped bidomain model. The short QT mutation led to an obvious abbreviation of the QT interval caused by the increased outward potassium current IKr (Fig. 9). It was reduced from 339 ms in the wild-type to 253 ms in the mutant case. The homogenization of the repolarization in the mutant tissue yielded a T wave with reduced amplitude.
|
| Discussion |
|---|
|
|
|---|
In this work, our heterogeneous formulation of the PriebeBeuckelmann electrophysiological model of a human cardiac myocytes [33,
As in the experiment the mutation abolished the rectification of the IKr current and caused a linear increase in the IKr activity over the range of physiological potentials. The decay of the tail current was significantly accelerated. The IKr current elicited during an action potential generated a waveform in the mutant modelling which was clearly distinguishable from the wild-type formulation. The altered characteristic of the mutant rapidly activating rectifier potassium current is consistent with the experimental findings. As in the measurement the short QT mutation led to an increase in this repolarizing ionic current during the early phases of repolarization. This gain of function in IKr reduced the repolarization time and produced markedly abbreviated APDs in the mutant compared with the wild-type case.
The impact of the short QT mutation in heterogeneous tissue was investigated in a thin parallelepiped domain as well as in a three-dimensional anatomical model. As shown, the heterogeneous electrophysiology is necessary to obtain an upright positive T wave in the approximate transmural ECG in wild-type case. In the short QT modelling the computed ECG displayed a noticeable decrease in the QT interval caused by shortened action potentials leading to a reduced repolarization time. The decrease in the T wave amplitude representing reduced dispersion of repolarization is in contrast with the assumption of Brugada et al.[12]
. They speculated that the heterogeneous distribution of the ion currents in the heart [49]
leads to heterogeneous abbreviations of APD in the short QT case. On the assumption that the reduction of the APD is less pronounced in M cells this behaviour would affect an accentuation of repolarization dispersion in coupled heterogeneous tissue visible as increased TpeakTend interval and thus, as widened T wave with increased amplitude in the transmural ECG [50,
51]
. In the computational simulations, the IKr current came to the foreground caused by the increase in its activity in cells emulating the behaviour of short QT affected cells. Thus, the transmurally homogeneous distributed IKr depleted the repolarizing effect of the heterogeneous distributed IKs [40]
and became the main repolarizing part. This homogenization of the repolarizing current reduced the APD differences between the distinctive cell types leading to a more pronounced abbreviation of the action potential in M cells compared with the remaining cardiomyocytes. Thus, the heterogeneous action potential shortening led to a reduced dispersion of repolarization that was visible as a T wave with reduced amplitude in the transmural ECG. A possible explanation for the difference between simulated ECGs and the assumption of the Brugada group is the assumed distribution and characteristics of the currents in the computer model.
Brugada et al. ascertained a reduced affinity of the IKr channel to IKr blockers caused by the mutation. Gaita et al.[52]
administered various antiarrhythmic drugs to patients with short QT affections and only hydroquinidine administration achieved QT prolongation. Although hydroquinidine has the potential to be an effective therapy for these individuals the long-term benefit has yet to be determined. The first-choice therapy so far is the implantable cardioverter defibrillator implantation [53]
. In the computational model the maximal IKr current was determined by the maximum conductance gKr,max of the IKr channel. Effects of IKr blockers will be estimated by reducing this value. The model is not able to reproduce reduced affinity of IKr blockers in the short QT mutation.
The model presented here can be expanded to investigate the effects of the genetic heterogeneity of the short QT syndrome. Bellocq et al.[9]
recently linked a G919C substitution in KCNQ1 encoding the cardiac KvLQT1 channel to the short QT syndrome (SQT2). This effects a V307L mutation in KvLQT1. The mutation manifests in a 20 mV shift of the half-activation potential and accelerated activation kinetics of IKs and results in a gain of function in the heterogeneous distributed IKs channel. Recently, Priori et al.[18]
described a novel form of the short QT syndrome (SQT3) due to a G514A substitution in KCNJ2. This results in a D172N amino acid change in Kir2.1, the inwardly rectifying IK1 channel. The current density of IK1 was increased and the peak of the current was shifted to a more positive value. By incorporating the three-dimensional heart model into a representation of the torso, simulations can be performed to uncover how changes in the heterogeneity of the short QT mutation affect the standard ECGs measured on the body surface.
| Footnotes |
|---|
1Present address: Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah, USA.
| References |
|---|
|
|
|---|
[1] Zipes DP and Wellens HJ. Sudden cardiac death. Circulation 1998; 98: 23342351.
[2] Priori SG, Barhanin J, Hauer RN, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation 1999; 99: 518528.
[3] Priori SG, Barhanin J, Hauer RN, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III. Circulation 1999; 99: 674681.
[4] Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KvLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996; 12: 1723.[CrossRef][Web of Science][Medline]
[5] Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 1997; 17: 338340.[Web of Science][Medline]
[6] Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003; 299: 251254.
[7] Brugada R, Tapscott T, Czernuszewicz GZ, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997; 336: 905911.
[8] Eckardt L, Kirchhof P, Loh P, et al. Brugada syndrome and supraventricular tachyarrhythmias: a novel association? J Cardiovasc Electrophysiol 2001; 12: 680685.[CrossRef][Web of Science][Medline]
[9] Bellocq C, van Ginneken AC, Bezzina CR, et al. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 2004; 109: 23942397.
[10] Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995; 80: 795803.[CrossRef][Web of Science][Medline]
[11] Abbott GW, Sesti F, Splawski I, et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999; 97: 175187.[CrossRef][Web of Science][Medline]
[12] Brugada R, Hong K, Dumaine R, et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004; 109: 3035.
[13] Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995; 80: 805811.[CrossRef][Web of Science][Medline]
[14] Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392: 293296.[CrossRef][Medline]
[15] Baroudi G, Napolitano C, Priori SG, Del Bufalo A, Chahine M. Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome. Can J Cardiol 2004; 20: 425430.[Web of Science][Medline]
[16] Kyndt F, Probst V, Potet F, et al. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation 2001; 104: 30813086.
[17] Plaster NM, Tawil R, Tristani-Firouzi M, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001; 105: 511519.[CrossRef][Web of Science][Medline]
[18] Priori SG, Pandit SV, Rivolta I, et al. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 2005; 96: 800807.
[19] Schott JJ, Charpentier F, Peltier S, et al. Mapping of a gene for long QT syndrome to chromosome 4q2527. Am J Hum Genet 1995; 57: 11141122.[Web of Science][Medline]
[20] Keating M, Dunn C, Atkinson D, Timothy K, Vincent GM, Leppert M. Consistent linkage of the long-QT syndrome to the Harvey ras-1 locus on chromosome 11. Am J Hum Genet 1991; 49: 13351339.[Web of Science][Medline]
[21] Keating M, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 1991; 252: 704706.
[22] Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. QT interval variables from 24 h electrocardiography and the two year risk of sudden death. Br Heart J 1993; 70: 4348.
[23] Gussak I, Brugada P, Brugada J, et al. Idiopathic short QT interval: a new clinical syndrome? Cardiology 2000; 94: 99102.[CrossRef][Web of Science][Medline]
[24] Gaita F, Giustetto C, Bianchi F, et al. Short QT Syndrome: a familial cause of sudden death. Circulation 2003; 108: 965970.
[25] Roden DM and George AL Jr. Structure and function of cardiac sodium and potassium channels. Am J Physiol 1997; 273: H511H525.[Web of Science][Medline]
[26] Guy HR and Durell SR. Structural models of Nay, Ca2+, and K+ channels. Soc Gen Physiol Ser 1995; 50: 116.[Medline]
[27] Kukuljan M, Labarca P, Latorre R. Molecular determinants of ion conduction and inactivation in K+ channels. Am J Physiol 1995; 268: C535C556.[Medline]
[28] Heginbotham L, Lu Z, Abramson T, MacKinnon R. Mutations in the K+ channel signature sequence. Biophys J 1994; 66: 10611067.[Web of Science][Medline]
[29] Doyle DA, Morais Cabral J, Pfuetzner RA, et al. The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science 1998; 280: 6977.
[30] Ficker E, Jarolimek W, Kiehn J, Baumann A, Brown AM. Molecular determinants of dofetilide block of HERG K+ channels. Circ Res 1998; 82: 386395.
[31] Tseng GN. I(Kr): the hERG channel. J Mol Cell Cardiol 2001; 33: 835849.[CrossRef][Web of Science][Medline]
[32] Sachse FB, Seemann G, Chaisaowong K, Mohr MB. Modeling of electro-mechanics of human cardiac myocytes: parametrization with numerical minimization techniques. Proc 25th Conf IEEE EMBS 2003; 28102813.
[33] Priebe L and Beuckelmann DJ. Simulation study of cellular electric properties in heart failure. Circ Res 1998; 82: 12061223.
[34] Seemann G, Sachse FB, Weiss DL, Dossel O. Quantitative reconstruction of cardiac electromechanics in human myocardium: regional heterogeneity. J Cardiovasc Electrophysiol 2003; 14:10 Suppl. S219S228.[CrossRef][Web of Science][Medline]
[35] Hodgkin AL and Huxley AF. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol 1952; 117: 500544.
[36] Press WH, Teukolsky SA, Vetterling WT, Flannery BP, Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Integration of ordinary differential equations. Numerical recipes in C: the art of scientific computing 1992; 2nd ed. Cambridge, UK Cambridge University Press pp. 707752.
[37] Hille B and Hille B. Classical biophysics of the squid giant axon. Ionic channels of excitable membranes 2001; 3rd ed. Sunderland, Mass, USA Sinauer pp. 2560.
[38] Antzelevitch C, Yan G, Shimizu W, Burashnikov A, Zipes DP, Jalife J. Electrical heterogeneity, the ECG, and cardiac arrhythmics. Cardiac electrophysiology. From cell to bedside 1999; 3rd ed. W.B. Saunders Company pp. 222238.
[39] Li GR, Feng J, Yue L, Carrier M. Transmural heterogeneity of action potentials and Ito1 in myocytes isolated from the human right ventricle. Am J Physiol 1998; 275: H369H377.[Web of Science][Medline]
[40] Liu DW and Antzelevitch C. Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial, and endocardial myocytes. A weaker IKs contributes to the longer action potential of the M cell. Circ Res 1995; 76: 351365.
[41] Zygmunt AC, Goodrow RJ, Antzelevitch C. I(NaCa) contributes to electrical heterogeneity within the canine ventricle. Am J Physiol Heart Circ Physiol 2000; 278: H1671H1678.
[42] Weiss DL, Seemann G, Dössel O. Conditions for equal polarity of R and T wave in heterogenous human ventricular tissue. Proc BMT 2004; 49: 364365.
[43] Henriquez CS. Simulating the electrical behavior of cardiac tissue using the bidomain model. Crit Rev Biomed Eng 1993; 21: 177.[Web of Science][Medline]
[44] Henriquez CS, Muzikant AL, Smoak CK. Anisotropy, fiber curvature, and bath loading effects on activation in thin and thick cardiac tissue preparations: simulations in a three-dimensional bidomain model. J Cardiovasc Electrophysiol 1996; 7: 424444.[Web of Science][Medline]
[45] Visible Human Project, National Library of Medicine, Bethesda, USA: <http://www.nlm.nih.gov/research/visible/visible_human.html>.
[46] Sachse FB, Werner CD, Stenroos MH, Schulte RF, Zerfass P, Dössel O. Modeling the anatomy of the human heart using the cryosection images of the Visible Female dataset. Proc Third Users Conference of the National Library of Medicine's Visible Human Project 2000; .
[47] Streeter DD. Gross morphology and fiber geometry of the heart. Handbook of physiology. Am Physiol Soc 1979; pp. 61112.
[48] The message passing interface (MPI) standard: <http://www-unix.mcs.anl.gov/mpi>.
[49] Antzelevitch C, Dumaine R, Page E, Fozzard HA, Solaro RJ. Electrical heterogeneity in the heart: physiological, pharmalogical and clinical implications. Handbook of physiology: the heart 2001; Oxford, UK Oxford University Press pp. 654692.
[50] Antzelevitch C. T peak-Tend interval as an index of transmural dispersion of repolarization. Eur J Clin Invest 2001; 31: 555557.[CrossRef][Web of Science][Medline]
[51] Yan GX and Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 1998; 98: 19281936.
[52] Gaita F, Giustetto C, Bianchi F, et al. Short QT syndrome: pharmacological treatment. J Am Coll Cardiol 2004; 43: 14941499.
[53] Schimpf R, Wolpert C, Bianchi F, et al. Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery. J Cardiovasc Electrophysiol 2003; 14: 12731277.[CrossRef][Web of Science][Medline]
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


















